Retinoblastoma management during the COVID‐19 pandemic: A report by the Global Retinoblastoma Study Group including 194 centers from 94 countries
Ido Didi Fabian, Andrew W. Stacey, Richard Bowman, Vikas Khetan, Sharon Blum, Naama Keren‐Froim, Sandra E. Staffieri, Allen Foster, the Global Retinoblastoma Study Group
Abstract
We declare no competing interests relevant to the present work. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
PandemicRetinoblastomaCoronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyLibrary scienceFamily medicinePathologyGeneticsBiologyComputer scienceDiseaseInfectious disease (medical specialty)OutbreakGeneOcular Oncology and TreatmentsRetinal and Optic ConditionsOcular Diseases and Behçet’s Syndrome